Order Article Reprints

Bielack SS, Mettmann V, Baumhoer D, Blattmann C, Burkhardt B, Deinzer CKW, Kager L, Kevric M, Mauz-Körholz C, Müller-Abt P, et al. Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS). Cancers. 2024; 16(10):1836. https://doi.org/10.3390/cancers16101836

Bielack, Stefan S., Vanessa Mettmann, Daniel Baumhoer, Claudia Blattmann, Birgit Burkhardt, Christoph K. W. Deinzer, Leo Kager, Matthias Kevric, Christine Mauz-Körholz, Peter Müller-Abt, and et al. 2024. "Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS)" Cancers 16, no. 10: 1836. https://doi.org/10.3390/cancers16101836

Bielack, S. S., Mettmann, V., Baumhoer, D., Blattmann, C., Burkhardt, B., Deinzer, C. K. W., Kager, L., Kevric, M., Mauz-Körholz, C., Müller-Abt, P., Reinhardt, D., Sabo, A.-A., Schrappe, M., Sorg, B., Windhager, R., & Hecker-Nolting, S. (2024). Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS). Cancers, 16(10), 1836. https://doi.org/10.3390/cancers16101836